Evidence map›Paper›PMID 1677922›Full record

ArticleHuman genetics1991

Molecular characterization of a patient with del(1)(q23-q25).

B Franco, L W Lai, D Patterson, D H Ledbetter, B J Trask, G van den Engh, S Iannaccone, S Frances, P I Patel, J R Lupski

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Human genetics, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Myocilin misfolding and glaucoma: A 20-year update.Progress in retinal and eye research · 2023
    Review
  2. MicroRNAs in orthopaedic research: Disease associations, potential therapeutic applications, and perspectives.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2018
    Review
  3. Distinctive phenotype in 9 patients with deletion of chromosome 1q24-q25.American journal of medical genetics. Part A · 2011
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

B FrancoInstitute for Molecular Genetics, Baylor College of Medicine, Houston, TX 77030.
L W Lai
D Patterson
D H Ledbetter
B J Trask
G van den Engh
S Iannaccone
S Frances
P I Patel
J R Lupski
Baylor College of Medicine · USBaylor Genetics · USLawrence Livermore National Laboratory · USRoosevelt Institute · USScottish Rite Hospital · US

Funding

UNDERSTANDING FXTAS AMONG MALES WITH THE FMR1 PREMUTATIONP30HD024064 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI WESTBROOK, THOMAS · 1988 to 2013
$29.4M
CMT Peripheral Neuropathy: IV. Genes and PathogenesisR01NS027042 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI LUPSKI, JAMES R. · 1990 to 2005
$2.7M
MOLECULAR CYTOGENETICS IN PRE AND NEONATAL DIAGNOSISR01HD017665 · NICHD · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI PINKEL, DANIEL · 1985 to 1999
–
NICHD NIH HHS HD-17665NICHD NIH HHS HD 24064-02NINDS NIH HHS R01 NS-27042
6 · The paper itself

Abstract

We report a patient (S.T.) with multiple congenital anomalies and developmental delay associated with an interstitial deletion of 1q23-1q25. Molecular analysis of the deletion was performed using DNA markers that map to 1q. Five DNA markers, MLAJ-1 (D1S61), CRI-L1054 (D1S42), HBI40 (D1S66), OS-6 (D1S75), and BH516 (D1S110), were demonstrated to be deleted. Informative polymorphisms demonstrated this to be a de novo deletion of the maternally derived chromosome. Deletion status was determined using restriction fragment length polymorphism (RFLP) analysis supplemented with densitometry in the experiments where RFLP analysis was not fully informative. Deletions were confirmed by Southern analysis using genomic DNA from a somatic cell hybrid retaining the del(1)(q23-q25) chromosome that was constructed from patient S.T. Flow karyotyping confirmed the deletion and estimated that the deletion encompassed 11,000-16,000 kb. The clinical and cytogenetic characteristics of S.T. are compared with those of ten previously described patients with monosomy 1q21-1q25.

Indexed as

Chromosome DeletionChromosomes, Human, Pair 1Abnormalities, MultipleAdolescentAnimalsBlotting, SouthernCells, CulturedChromosome BandingChromosome MappingCricetinaeDNA ProbesFemaleFlow CytometryGenetic MarkersHumansHybrid CellsDNA ProbesGenetic Markers

Identifiers

PMID1677922
OpenAlexW2017417312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.